US Stock MarketDetailed Quotes

CERO CERo Therapeutics

Watchlist
  • 2.060
  • +0.260+14.44%
Close Feb 14 16:00 ET
  • 2.050
  • -0.010-0.49%
Post 19:53 ET
6.24MMarket Cap-0.01P/E (TTM)

About CERo Therapeutics Company

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.

Company Profile

SymbolCERO
Company NameCERo Therapeutics
Listing DateNov 30, 2021
Founded2021
CEOMr. Chris Ehrlich
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address201 Haskins Way,Suite 230
CityOakland
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-215-731-9450
Websitehttp://www.cero.bio

Company Executives

  • Name
  • Position
  • Salary
  • Chris Ehrlich
  • Interim Chairman of the Board and Chief Executive Officer
  • --
  • Andrew Albert Kucharchuk
  • Chief Financial Officer
  • --
  • Dr. Kristen Pierce, PhD
  • Chief Development Officer
  • --
  • Daniel Corey, M.D.
  • Chief Technical Officer and Director
  • 376.04K
  • Shami J. Patel
  • Director
  • --
  • Brian G. Atwood
  • Director
  • --
  • Kathleen D. Laporte
  • Director
  • --
  • Michael Byrnes
  • Director
  • --
  • Dr. Lindsey Rolfe, M.D.
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+29.99%
Beijing Highlander Digital Technology
300065
+20.05%
4
Hangzhou Gaoxin Materials Technology
300478
+20.02%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!